BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-shakrah M, Fich A, Buskila D. Fibromyalgia in The Irritable Bowel Syndrome: Studies of Prevalence and Clinical Implications. American Journal of Gastroenterology 1999;94:3541-6. [DOI: 10.1111/j.1572-0241.1999.01643.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 133] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Slim M, Calandre EP, Rico-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int 2015;35:433-44. [PMID: 25119830 DOI: 10.1007/s00296-014-3109-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
2 Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005;7:264-271. [PMID: 16042909 DOI: 10.1007/s11894-005-0018-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
3 Matheis A, Martens U, Kruse J, Enck P. Irritable bowel syndrome and chronic pelvic pain: A singular or two different clinical syndrome? World J Gastroenterol 2007; 13(25): 3446-3455 [PMID: 17659691 DOI: 10.3748/wjg.v13.i25.3446] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
4 Buskila D, Press J. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue. Best Pract Res Clin Rheumatol 2001;15:747-58. [PMID: 11812019 DOI: 10.1053/berh.2001.0191] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
5 Hassett AL, Clauw DJ. Does Psychological Stress Cause Chronic Pain? Psychiatric Clinics of North America 2011;34:579-94. [DOI: 10.1016/j.psc.2011.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
6 Yunus MB. Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes. Seminars in Arthritis and Rheumatism 2007;36:339-56. [DOI: 10.1016/j.semarthrit.2006.12.009] [Cited by in Crossref: 418] [Cited by in F6Publishing: 351] [Article Influence: 27.9] [Reference Citation Analysis]
7 Sperber AD, Drossman DA. Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective. Therap Adv Gastroenterol. 2012;5:387-393. [PMID: 23152732 DOI: 10.1177/1756283x12460420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
8 Haddad HW, Mallepalli NR, Scheinuk JE, Bhargava P, Cornett EM, Urits I, Kaye AD. The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review. Pain Ther 2021. [PMID: 33909266 DOI: 10.1007/s40122-021-00266-9] [Reference Citation Analysis]
9 Aggarwal V, Macfarlane G, Mcbeth J. A high tender point count is associated with the presence of multiple idiopathic pain disorders: Results from a population study: Mechanical hyperalgesia in idiopathic pain disorders. EJP 2012;16:1195-203. [DOI: 10.1002/j.1532-2149.2012.00127.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Borji R, Fereshtehnejad SM, Taba Taba Vakili S, Daryani NE, Ajdarkosh H. Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group. J Neurogastroenterol Motil 2012;18:426-33. [PMID: 23106004 DOI: 10.5056/jnm.2012.18.4.426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ballou S, Bedell A, Keefer L. Psychosocial impact of irritable bowel syndrome: A brief review. World J Gastrointest Pathophysiol 2015; 6(4): 120-123 [PMID: 26600969 DOI: 10.4291/wjgp.v6.i4.120] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
12 Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci. 2008;53:1252-1256. [PMID: 17934858 DOI: 10.1007/s10620-007-0021-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
13 Green PG, Alvarez P, Gear RW, Mendoza D, Levine JD. Further validation of a model of fibromyalgia syndrome in the rat. J Pain 2011;12:811-8. [PMID: 21481648 DOI: 10.1016/j.jpain.2011.01.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
14 Heitkemper M, Carter E, Ameen V, Olden K, Cheng L. Women With Irritable Bowel Syndrome: Differences in Patients’ and Physicians’ Perceptions. Gastroenterology Nursing 2002;25:192-200. [DOI: 10.1097/00001610-200209000-00004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
15 Larson AA, Nunez MG, Kissel CL, Kovács KJ. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia. Eur J Neurosci 2015;42:2772-82. [PMID: 26332847 DOI: 10.1111/ejn.13060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
16 Simrén M, Svedlund J, Posserud I, Bjornsson ES, Abrahamsson H. Predictors of subjective fatigue in chronic gastrointestinal disease. Aliment Pharmacol Ther 2008;28:638-47. [PMID: 18564325 DOI: 10.1111/j.1365-2036.2008.03770.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci. 2006;51:454-460. [PMID: 16614951 DOI: 10.1007/s10620-006-3154-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
18 Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6:26. [PMID: 17007634 DOI: 10.1186/1471-230x-6-26] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
19 Zhang Z, Feng J, Mao A, Le K, La Placa D, Wu X, Longmate J, Marek C, St Amand RP, Neuhausen SL, Shively JE. SNPs in inflammatory genes CCL11, CCL4 and MEFV in a fibromyalgia family study. PLoS One 2018;13:e0198625. [PMID: 29927949 DOI: 10.1371/journal.pone.0198625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 2005;58:1090-100. [PMID: 16223651 DOI: 10.1016/j.jclinepi.2005.03.011] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
21 Lind R, Berstad A, Hatlebakk J, Valeur J. Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale. Clin Exp Gastroenterol. 2013;6:101-107. [PMID: 23869173 DOI: 10.2147/ceg.s45760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
22 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
23 Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009;21:149-159. [PMID: 18684212 DOI: 10.1111/j.1365-2982.2008.01171.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 157] [Article Influence: 10.9] [Reference Citation Analysis]
24 Vicari E, La Vignera S, Arcoria D, Condorelli R, Vicari LO, Castiglione R, Mangiameli A, Calogero AE. High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome. PLoS One 2011;6:e18647. [PMID: 21494624 DOI: 10.1371/journal.pone.0018647] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
25 Gerson M, Gerson CD, Awad RA, Dancey C, Poitras P, Porcelli P, Sperber AD. An international study of irritable bowel syndrome: Family relationships and mind-body attributions. Social Science & Medicine 2006;62:2838-47. [DOI: 10.1016/j.socscimed.2005.10.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
26 Kehl LJ, Kovács KJ, Larson AA. Tolerance develops to the effect of lipopolysaccharides on movement-evoked hyperalgesia when administered chronically by a systemic but not an intrathecal route. Pain 2004;111:104-15. [PMID: 15327814 DOI: 10.1016/j.pain.2004.06.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
27 Berstad A, Undseth R, Lind R, Valeur J. Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol. 2012;47:914-919. [PMID: 22594347 DOI: 10.3109/00365521.2012.690045] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
28 Hasler WL. The irritable bowel syndrome. Med Clin North Am. 2002;86:1525-1551. [PMID: 12510463 DOI: 10.1016/S0025-7125(02)00086-X] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 Brugnatelli V, Turco F, Freo U, Zanette G. Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment. Front Neurosci 2020;14:371. [PMID: 32372912 DOI: 10.3389/fnins.2020.00371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Thielecke F, Maxion-bergemann S, Abel F, Gonschior A. Update in the pharmaceutical therapy of the irritable bowel syndrome: Pharmaceutical Therapy of the Irritable Bowel Syndrome. International Journal of Clinical Practice 2004;58:374-81. [DOI: 10.1111/j.1368-5031.2004.00136.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
31 Erdrich S, Hawrelak JA, Myers SP, Harnett JE. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol 2020;13:1756284820977402. [PMID: 33343707 DOI: 10.1177/1756284820977402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Hod K, Ringel Y, van Tilburg MAL, Ringel-Kulka T. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities. Dig Dis Sci 2019;64:1288-95. [PMID: 30565010 DOI: 10.1007/s10620-018-5352-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Champey J, Corruble E, Gottenberg J, Buhl C, Meyer T, Caudmont C, Bergé E, Pellet J, Hardy P, Mariette X. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006;55:451-7. [DOI: 10.1002/art.21990] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
34 Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A, Marchand S. Comparing Pain Modulation and Autonomic Responses in Fibromyalgia and Irritable Bowel Syndrome Patients. The Clinical Journal of Pain 2012;28:519-26. [DOI: 10.1097/ajp.0b013e31823ae69e] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
35 Englund H, Lidén K K, Lind T, Sundström T, Karling P. Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001-2011. Scand J Gastroenterol 2017;52:300-5. [PMID: 27832710 DOI: 10.1080/00365521.2016.1252945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Fink P, Toft T, Hansen MS, Ørnbøl E, Olesen F. Symptoms and Syndromes of Bodily Distress: An Exploratory Study of 978 Internal Medical, Neurological, and Primary Care Patients: . Psychosomatic Medicine 2007;69:30-9. [DOI: 10.1097/psy.0b013e31802e46eb] [Cited by in Crossref: 183] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
37 Wallace DJ, Hallegua DS. Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep 2004;8:364-8. [PMID: 15361320 DOI: 10.1007/s11916-996-0009-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
38 MacLean EW, Palsson OS, Turner MJ, Whitehead WE. Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res. 2012;73:351-355. [PMID: 23062808 DOI: 10.1016/j.jpsychores.2012.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
39 Alander T, Svärdsudd K, Johansson SE, Agréus L. Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study. BMC Med 2005;3:8. [PMID: 15892883 DOI: 10.1186/1741-7015-3-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
40 Narayanan SP, Anderson B, Bharucha AE. Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders. Mayo Clin Proc 2021;96:1071-89. [PMID: 33814075 DOI: 10.1016/j.mayocp.2020.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Wang B, Duan R, Duan L. Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis. Saudi J Gastroenterol 2018;24:141-50. [PMID: 29652034 DOI: 10.4103/sjg.SJG_603_17] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
42 Farup PG, Sperber AD, Simrén M. Irritable bowel syndrome. Gastroenterol Res Pract 2012;2012:612479. [PMID: 22745635 DOI: 10.1155/2012/612479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol. 2009;31-74. [PMID: 19655104 DOI: 10.1007/978-3-540-79090-7_2] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 8.6] [Reference Citation Analysis]
44 Rodrigo L, Blanco I, Bobes J, de Serres FJ. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study. Arthritis Res Ther 2014;16:421. [PMID: 25160886 DOI: 10.1186/s13075-014-0421-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
45 Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol. 2004;28:11-15. [PMID: 15041804 DOI: 10.1016/s0399-8320(04)94834-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
46 Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics. 2001;19:643-653. [PMID: 11456212 DOI: 10.2165/00019053-200119060-00003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 2.8] [Reference Citation Analysis]
47 Bennett RM. The rational management of fibromyalgia patients. Rheumatic Disease Clinics of North America 2002;28:181-99. [DOI: 10.1016/s0889-857x(02)00002-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
48 olden KW. Psychosocial factors in functional gastrointestinal disorders: an evolving phenomenon. Neurogastroenterol Motil 2008;20:114-20. [DOI: 10.1111/j.1365-2982.2008.01112.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
49 Erdrich S, Hawrelak JA, Myers SP, Harnett JE. Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord 2020;21:181. [PMID: 32192466 DOI: 10.1186/s12891-020-03201-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
50 Heitkemper M, Olden K, Gordon S, Carter E, Chang L. Irritable Bowel Syndrome: A Survey of Nurses??? Knowledge. Gastroenterology Nursing 2001;24:281-7. [DOI: 10.1097/00001610-200111000-00005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
51 Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71-80. [PMID: 24523597 DOI: 10.2147/clep.s40245] [Cited by in Crossref: 101] [Cited by in F6Publishing: 242] [Article Influence: 12.6] [Reference Citation Analysis]
52 Maquet D, Demoulin C, Croisier J, Crielaard J. Benefits of physical training in fibromyalgia and related syndromes. Annales de Réadaptation et de Médecine Physique 2007;50:363-8. [DOI: 10.1016/j.annrmp.2007.03.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
53 Marinus J, Van Hilten JJ. Clinical expression profiles of complex regional pain syndrome, fibromyalgia and a-specific repetitive strain injury: More common denominators than pain? Disability and Rehabilitation 2009;28:351-62. [DOI: 10.1080/09638280500287320] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
54 Akkuş S, Senol A, Ayvacioglu NB, Tunc E, Eren I, Isler M. Is female predominance in irritable bowel syndrome related to fibromyalgia? Rheumatol Int 2004;24:106-9. [PMID: 12879267 DOI: 10.1007/s00296-003-0328-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
55 Staud R. Mechanisms of Fibromyalgia Pain. CNS Spectr 2009;14:4-5. [DOI: 10.1017/s1092852900027991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
56 Buskila D, Neumann L, Press J. Genetic Factors in Neuromuscular Pain. CNS spectr 2005;10:281-4. [DOI: 10.1017/s1092852900022604] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
57 Almansa C, Rey E, Sánchez RG, Sánchez ÁÁ, Díaz–rubio M. Prevalence of Functional Gastrointestinal Disorders in Patients With Fibromyalgia and the Role of Psychologic Distress. Clinical Gastroenterology and Hepatology 2009;7:438-45. [DOI: 10.1016/j.cgh.2008.12.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
58 Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol 2007;21:535-47. [PMID: 17602998 DOI: 10.1016/j.berh.2007.02.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
59 Yang TY, Chen CS, Lin CL, Lin WM, Kuo CN, Kao CH. Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study. Medicine (Baltimore) 2017;96:e6657. [PMID: 28383443 DOI: 10.1097/MD.0000000000006657] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
60 Itoh Y, Shigemori T, Igarashi T, Fukunaga Y. Fibromyalgia and chronic fatigue syndrome in children. Pediatr Int 2012;54:266-71. [PMID: 22115414 DOI: 10.1111/j.1442-200X.2011.03514.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
61 Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, Lyon JL. The Incidence of Fibromyalgia and Its Associated Comorbidities: A Population-Based Retrospective Cohort Study Based on International Classification of Diseases, 9th Revision Codes. JCR: Journal of Clinical Rheumatology 2006;12:124-8. [DOI: 10.1097/01.rhu.0000221817.46231.18] [Cited by in Crossref: 192] [Cited by in F6Publishing: 160] [Article Influence: 12.0] [Reference Citation Analysis]
62 Camilleri M. Sex as a biological variable in irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13802. [PMID: 31943595 DOI: 10.1111/nmo.13802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Clauw DJ, Williams DA. Relationship between stress and pain in work-related upper extremity disorders: The hidden role of chronic multisymptom illnesses. Am J Ind Med 2002;41:370-82. [DOI: 10.1002/ajim.10068] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
64 Staud R. Evidence for Shared Pain Mechanisms in Osteoarthritis, Low Back Pain, and Fibromyalgia. Curr Rheumatol Rep 2011;13:513-20. [DOI: 10.1007/s11926-011-0206-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
65 Cohen H, Jotkowitz A, Buskila D, Pelles-avraham S, Kaplan Z, Neumann L, Sperber AD. Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome. European Journal of Internal Medicine 2006;17:567-71. [DOI: 10.1016/j.ejim.2006.07.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
66 Yildiz A, Kizil E, Yildiz A. Quality of life and psychometric evaluation of patients diagnosed with irritable bowel syndrome: an observational cohort study. Sao Paulo Med J 2020;138:282-6. [PMID: 32556060 DOI: 10.1590/1516-3180.2019.0527.R1.16042020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ma KS, Lai JN, Veeravalli JJ, Chiu LT, Van Dyke TE, Wei JC. Fibromyalgia and periodontitis: Bidirectional associations in population-based 15-year retrospective cohorts. J Periodontol 2021. [PMID: 34542911 DOI: 10.1002/JPER.21-0256] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Spiegel B, Strickland A, Naliboff BD, Mayer EA, Chang L. Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol 2008;103:2536-43. [PMID: 18637089 DOI: 10.1111/j.1572-0241.2008.01997.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 6.1] [Reference Citation Analysis]
69 Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003;1:60. [PMID: 14613562 DOI: 10.1186/1477-7525-1-60] [Cited by in Crossref: 273] [Cited by in F6Publishing: 230] [Article Influence: 14.4] [Reference Citation Analysis]
70 Ablin K, Clauw DJ. From Fibrositis to Functional Somatic Syndromes to a Bell-Shaped Curve of Pain and Sensory Sensitivity: Evolution of a Clinical Construct. Rheumatic Disease Clinics of North America 2009;35:233-51. [DOI: 10.1016/j.rdc.2009.06.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
71 Aaron LA, Buchwald D. Fibromyalgia and other unexplained clinical conditions. Curr Rheumatol Rep 2001;3:116-22. [PMID: 11286667 DOI: 10.1007/s11926-001-0006-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
72 Kindler LL, Bennett RM, Jones KD. Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag Nurs 2011;12:15-24. [PMID: 21349445 DOI: 10.1016/j.pmn.2009.10.003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 6.8] [Reference Citation Analysis]
73 Maquet D, Demoulin C, Croisier J, Crielaard J. Intérêts du réentraînement à l'effort dans la fibromyalgie et autres syndromes apparentés. Annales de Réadaptation et de Médecine Physique 2007;50:356-62. [DOI: 10.1016/j.annrmp.2007.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Sahan HE, Yildirim EA, Soylu A, Tabakci AS, Cakmak S, Erkoc SN. Comparison of functional dyspepsia with organic dyspepsia in terms of attachment patterns. Compr Psychiatry 2018;83:12-8. [PMID: 29501961 DOI: 10.1016/j.comppsych.2018.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
75 Depoortère R, Meleine M, Bardin L, Aliaga M, Muller E, Ardid D, Newman-tancredi A. Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents. European Journal of Pharmacology 2011;672:83-7. [DOI: 10.1016/j.ejphar.2011.09.182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
76 Iovino P, Tremolaterra F, Consalvo D, Sabbatini F, Mazzacca G, Ciacci C. Perception of electrocutaneous stimuli in irritable bowel syndrome. Am J Gastroenterol. 2006;101:596-603. [PMID: 16464229 DOI: 10.1111/j.1572-0241.2006.00414.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
77 Kovács KJ, Papic JC, Larson AA. Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids. Pain 2008;136:75-84. [PMID: 17686584 DOI: 10.1016/j.pain.2007.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
78 Slim M, Molina-barea R, Garcia-leiva JM, Rodríguez-lopez CM, Morillas-arques P, Rico-villademoros F, Calandre EP. The effects of gluten-free diet versus hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity symptoms: Protocol for a pilot, open-label, randomized clinical trial. Contemporary Clinical Trials 2015;40:193-8. [DOI: 10.1016/j.cct.2014.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
79 Shaver JL. Sleep Disturbed by Chronic Pain in Fibromyalgia, Irritable Bowel, and Chronic Pelvic Pain Syndromes. Sleep Medicine Clinics 2008;3:47-60. [DOI: 10.1016/j.jsmc.2007.10.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
80 Yun C, Lee SK, Kim H, Park H, Lee SH, Kim SJ, Shin C. Association between irritable bowel syndrome and restless legs syndrome in the general population: Irritable bowel syndrome and restless legs syndrome. Journal of Sleep Research 2012;21:569-76. [DOI: 10.1111/j.1365-2869.2012.01011.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
81 Sperber AD, Akiva S, Leshno M, Halpern Z, Buskila D. Validation of New Symptom-Based Fibromyalgia Criteria for Irritable Bowel Syndrome Co-morbidity Studies. J Neurogastroenterol Motil 2011;17:67-72. [PMID: 21369494 DOI: 10.5056/jnm.2011.17.1.67] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Chopra K, Kuhad A, Arora V. Neoteric pharmacotherapeutic targets in fibromyalgia. Expert Opinion on Therapeutic Targets 2011;15:1267-81. [DOI: 10.1517/14728222.2011.617366] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
83 Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. 2012;2012:584573. [PMID: 22191024 DOI: 10.1155/2012/584573] [Cited by in Crossref: 34] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
84 Hieblinger R, Coenen M, Stucki G, Winkelmann A, Cieza A. Validation of the International Classification of Functioning, Disability and Health Core Set for chronic widespread pain from the perspective of fibromyalgia patients. Arthritis Res Ther 2009;11:R67. [PMID: 19442275 DOI: 10.1186/ar2696] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
85 Tore Gran J. The epidemiology of chronic generalized musculoskeletal pain. Best Practice & Research Clinical Rheumatology 2003;17:547-61. [DOI: 10.1016/s1521-6942(03)00042-1] [Cited by in Crossref: 184] [Cited by in F6Publishing: 60] [Article Influence: 9.7] [Reference Citation Analysis]
86 Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017;33:1191-1197. [PMID: 28166427 DOI: 10.1080/03007995.2017.1292230] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
87 Fitzcharles MA, Perrot S, Häuser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur J Pain 2018;22:1565-76. [PMID: 29802812 DOI: 10.1002/ejp.1252] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
88 Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut. 2004;53:1452-1458. [PMID: 15361494 DOI: 10.1136/gut.2003.035451] [Cited by in Crossref: 176] [Cited by in F6Publishing: 171] [Article Influence: 9.8] [Reference Citation Analysis]
89 Shiha MG, Aziz I. Review article: Physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther 2021;54 Suppl 1:S12-23. [PMID: 34927759 DOI: 10.1111/apt.16589] [Reference Citation Analysis]
90 Paiva ES, Jones KD. Rational treatment of fibromyalgia for a solo practitioner. Best Pract Res Clin Rheumatol 2010;24:341-52. [PMID: 20534368 DOI: 10.1016/j.berh.2009.12.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
91 García-leiva JM, Carrasco JLO, Slim M, Calandre EP. Celiac symptoms in patients with fibromyalgia: a cross-sectional study. Rheumatol Int 2015;35:561-7. [DOI: 10.1007/s00296-014-3110-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
92 Wojczynski MK, North KE, Pedersen NL, Sullivan PF. Irritable bowel syndrome: a co-twin control analysis. Am J Gastroenterol. 2007;102:2220-2229. [PMID: 17897337 DOI: 10.1111/j.1572-0241.2007.01479.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
93 Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 2007;23:323-30. [PMID: 17449993 DOI: 10.1097/AJP.0b013e318032e496] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
94 Lacy BE, Rosemore J, Robertson D, Corbin DA, Grau M, Crowell MD. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scand J Gastroenterol 2006;41:892-902. [PMID: 16803687 DOI: 10.1080/00365520600554451] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
95 Yang TY, Chen CS, Lin CL, Lin WM, Kuo CN, Kao CH. Risk for irritable bowel syndrome in fibromyalgia patients: a national database study. Medicine (Baltimore) 2015;94:e616. [PMID: 25761187 DOI: 10.1097/MD.0000000000000616] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
96 Shiotani A, Kusunoki H, Kimura Y, Ishii M, Imamura H, Tarumi K, Manabe N, Kamada T, Hata J, Haruma K. S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci. 2013;58:2314-2323. [PMID: 23595519 DOI: 10.1007/s10620-013-2677-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
97 Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol. 2010;7:565-581. [PMID: 20890316 DOI: 10.1038/nrgastro.2010.137] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
98 Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjölund K, Björnsson ES, Simrèn M. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil. 2005;17:697-704. [PMID: 16185308 DOI: 10.1111/j.1365-2982.2005.00679.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
99 Sayuk GS, Elwing JE, Lustman PJ, Clouse RE. High Somatic Symptom Burdens and Functional Gastrointestinal Disorders. Clinical Gastroenterology and Hepatology 2007;5:556-62. [DOI: 10.1016/j.cgh.2006.11.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
100 Reitblat T, Zamir D, Polishchuck I, Novochatko G, Malnick S, Kalichman L. Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clin Rheumatol 2009;28:1079-82. [PMID: 19468788 DOI: 10.1007/s10067-009-1194-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
101 Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140-1156. [PMID: 11910364 DOI: 10.1053/gast.2002.32392] [Cited by in Crossref: 710] [Cited by in F6Publishing: 653] [Article Influence: 35.5] [Reference Citation Analysis]
102 Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 2006; 12(48): 7844-7847 [PMID: 17203531 DOI: 10.3748/wjg.v12.i48.7844] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
103 Tremolaterra F, Gallotta S, Morra Y, Lubrano E, Ciacci C, Iovino P. The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli. BMC Gastroenterol 2014;14:182. [PMID: 25323092 DOI: 10.1186/1471-230X-14-182] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
104 Shleyfer E, Jotkowitz A, Karmon A, Nevzorov R, Cohen H, Buskila D. Accuracy of the diagnosis of fibromyalgia by family physicians: is the pendulum shifting? J Rheumatol 2009;36:170-3. [PMID: 19040299 DOI: 10.3899/jrheum.080468] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
105 Tillisch K, Chang L. Diagnosis and treatment of irritable bowel syndrome: State of the art. Curr Gastroenterol Rep 2005;7:249-56. [DOI: 10.1007/s11894-005-0016-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
106 Olden KW, Brown AR. Treatment of the severe refractory irritable bowel patient. Curr Treat Options Gastroenterol. 2006;9:324-330. [PMID: 16836951 DOI: 10.1007/s11938-006-0014-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
107 Sperber AD, Dekel R. Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil. 2010;16:113-119. [PMID: 20535341 DOI: 10.5056/jnm.2010.16.2.113] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
108 Hausteiner-Wiehle C, Henningsen P. Irritable bowel syndrome: Relations with functional, mental, and somatoform disorders. World J Gastroenterol 2014; 20(20): 6024-6030 [PMID: 24876725 DOI: 10.3748/wjg.v20.i20.6024] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
109 Mathur R, Ko A, Hwang LJ, Low K, Azziz R, Pimentel M. Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci. 2010;55:1085-1089. [PMID: 19697132 DOI: 10.1007/s10620-009-0890-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
110 Roman P, Carrillo-Trabalón F, Sánchez-Labraca N, Cañadas F, Estévez AF, Cardona D. Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Benef Microbes 2018;9:603-11. [PMID: 29695180 DOI: 10.3920/BM2017.0125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
111 Scully P, McKernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Quigley EM. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010;105:2235-2243. [PMID: 20407431 DOI: 10.1038/ajg.2010.159] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 9.0] [Reference Citation Analysis]
112 García Carrasco M, Mendoza Pinto C, López Colombo A, Méndez Martínez S, Andari Sawaya R, Muñoz Guarneros M, Vázquez De Lara L, Lescas Hernández M, Montiel Jarquín A, Ramos Álvarez G, Schmulson M. Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life. Neurogastroenterol Motil 2013;25:958-66. [DOI: 10.1111/nmo.12230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
113 Mathieu N. Comorbidités somatiques dans le Syndrome de l’Intestin Irritable : fibromyalgie, syndrome de fatigue chronique et cystite interstitielle/syndrome de la vessie douloureuse. Gastroentérologie Clinique et Biologique 2009;33:S17-25. [DOI: 10.1016/s0399-8320(09)71521-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Basu PP, Shah NJ, Krishnaswamy N, Pacana T. Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroenterol 2011; 17(39): 4404-4407 [PMID: 22110266 DOI: 10.3748/wjg.v17.i39.4404] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
115 Soares RL. Irritable bowel syndrome: A clinical review. World J Gastroenterol 2014; 20(34): 12144-12160 [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 83] [Article Influence: 11.8] [Reference Citation Analysis]
116 Olden KW. Approach to the patient with severe, refractory irritable bowel syndrome. Curr Treat Options Gastro 2003;6:311-7. [DOI: 10.1007/s11938-003-0023-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
117 Thompson D, Lettich L, Takeshita J. Fibromyalgia: An overview. Curr Psychiatry Rep 2003;5:211-7. [DOI: 10.1007/s11920-003-0045-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
118 Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003;7:362-8. [PMID: 12946289 DOI: 10.1007/s11916-003-0035-z] [Cited by in Crossref: 169] [Cited by in F6Publishing: 145] [Article Influence: 8.9] [Reference Citation Analysis]
119 Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 2003;17:563-74. [PMID: 12849712 DOI: 10.1016/s1521-6942(03)00033-0] [Cited by in Crossref: 104] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
120 Faresjö Å, Grodzinsky E, Hallert C, Timpka T. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health 2013;13:832. [PMID: 24025070 DOI: 10.1186/1471-2458-13-832] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
121 Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 2001;13:117-27. [PMID: 11224736 DOI: 10.1097/00002281-200103000-00005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
122 Russo EB. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis Cannabinoid Res 2016;1:154-65. [PMID: 28861491 DOI: 10.1089/can.2016.0009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
123 Weinstock LB, Pace LA, Rezaie A, Afrin LB, Molderings GJ. Mast Cell Activation Syndrome: A Primer for the Gastroenterologist. Dig Dis Sci 2021;66:965-82. [PMID: 32328892 DOI: 10.1007/s10620-020-06264-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
124 Rodrigo L, Blanco I, Bobes J, de Serres FJ. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther 2013;15:R201. [PMID: 24283458 DOI: 10.1186/ar4391] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
125 Miranda A, Peles S, Mclean PG, Sengupta JN. Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. Pain 2006;126:54-63. [DOI: 10.1016/j.pain.2006.06.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
126 Buskila D. Fibromyalgia: The diagnosis and pharmacologic treatment. European Journal of Pain Supplements 2009;3:111-5. [DOI: 10.1016/j.eujps.2009.07.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
127 Camilleri M, Heading RC, Thompson WG. Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome: EPIDEMIOLOGY, MECHANISMS AND MANAGEMENT OF IBS. Alimentary Pharmacology & Therapeutics 2002;16:1407-30. [DOI: 10.1046/j.1365-2036.2002.01305.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
128 Krypel LL. Fibromyalgia: A Review of Its Pathophysiology and Drug Treatment. Journal of Pharmacy Practice 2009;22:6-16. [DOI: 10.1177/0897190008322151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
129 Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 2017;37:1527-39. [DOI: 10.1007/s00296-017-3725-2] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 16.6] [Reference Citation Analysis]
130 Hunskar GS, Rortveit G, Litleskare S, Eide GE, Hanevik K, Langeland N, Wensaas KA. Prevalence of fibromyalgia 10 years after infection with Giardia lamblia: a controlled prospective cohort study. Scand J Pain 2021. [PMID: 34679267 DOI: 10.1515/sjpain-2021-0122] [Reference Citation Analysis]
131 Feng J, Zhang Z, Li W, Shen X, Song W, Yang C, Chang F, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE, Sommer SS. Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One 2009;4:e8480. [PMID: 20041150 DOI: 10.1371/journal.pone.0008480] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
132 Mu R, Li C, Zhu JX, Zhang XY, Duan TJ, Feng M, Wang GC, Zhang FC, Li ZG. National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis 2013;16:258-63. [PMID: 23981745 DOI: 10.1111/1756-185X.12055] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
133 Barkhuizen A. Rational and targeted pharmacologic treatment of fibromyalgia. Rheumatic Disease Clinics of North America 2002;28:261-90. [DOI: 10.1016/s0889-857x(01)00011-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
134 Rodrigo L, Blanco I, Bobes J, de Serres FJ. Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease. BMC Gastroenterol 2013;13:157. [PMID: 24209578 DOI: 10.1186/1471-230X-13-157] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
135 Larson AA, Pardo JV, Pasley JD. Review of overlap between thermoregulation and pain modulation in fibromyalgia. Clin J Pain 2014;30:544-55. [PMID: 23887348 DOI: 10.1097/AJP.0b013e3182a0e383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
136 Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser A, Klapp BF, Mönnikes H. Somatic comorbidities of irritable bowel syndrome: A systematic analysis. Journal of Psychosomatic Research 2008;64:573-82. [DOI: 10.1016/j.jpsychores.2008.02.021] [Cited by in Crossref: 163] [Cited by in F6Publishing: 143] [Article Influence: 11.6] [Reference Citation Analysis]